Data / Form D filings / Salarius Pharmaceuticals, Inc.
Salarius Pharmaceuticals, Inc.: Form D filings
Salarius Pharmaceuticals, Inc., a biotechnology company in Houston, TX, filed 4 Form D notices with the SEC between 2014 and 2024. The latest, on December 27, 2024, reports an offering of $10 million with nothing sold yet to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2540 Holcombe Blvd., Suite X, Houston, TX, 77021
- Phone
- (832) 834-9144
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1615219
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 27, 2024 | New notice | $10,000,000 | $0 | $10,000,000 | 1 | Yet to occur | sec.gov |
| May 25, 2023 | New notice | $6,000,000 | $6,000,000 | 1 | May 11, 2023 | sec.gov | |
| May 5, 2022 | New notice | $2,334,859 | $2,334,859 | 4 | Apr 25, 2022 | sec.gov | |
| Aug 6, 2014 | New notice | $22,000,000 | $16,224,982 | $5,775,018 | 20 | Jul 23, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Arnold C. Hanish | Director | |
| Jonathan J. Lieber | Director | |
| Mark J. Rosenblum | Executive Officer | |
| William J. McVicar | Director | |
| Bruce J. McCreedy | Director | |
| Paul C. Lammers | Director | |
| Tess J. Burleson | Director | |
| David J. Arthur | Director, Executive Officer |
Other biotechnology companies in Texas that filed recently
- Nuclein, LLC $15.7 million · Oct 27, 2026
- OncoNano Medicine, Inc. $10.1 million · Oct 8, 2026
- Solaris Endovascular Inc. $5 million · Oct 1, 2026
- Hera Biotech, Inc. $1.7 million · Sep 23, 2026
- Kayak Therapeutics, Inc. $25 million · Aug 21, 2026
- InnovoTEX Inc. $2.7 million · Aug 18, 2026
Every Form D from the week of Dec 23, 2024 · All recent filings in Texas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Salarius Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.